Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Neurosci Lett. Author manuscript; available in PMC 2017 August 3.
Published in final edited form as:
PMCID: PMC5336362

Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner


Reduced α7 nicotinic acetylcholine receptor (nAChR) function is linked to impaired hippocampal-dependent sensory processing and learning and memory in schizophrenia. While knockout of the Chrna7 gene encoding the α7nAChR on a C57/Bl6 background results in changes in cognitive measures, prior studies found little impact on hippocampal synaptic plasticity in these mice. However, schizophrenia is a multi-genic disorder where complex interactions between specific genetic mutations and overall genetic background may play a prominent role in determining phenotypic penetrance. Thus, we compared the consequences of knocking out the α7nAChR on synaptic plasticity in C57/Bl6 and C3H mice, which differ in their basal α7nAChR expression levels. Homozygous α7 deletion in C3H mice, which normally express higher α7nAChR levels, resulted in impaired long-term potentiation (LTP) at hippocampal CA1 synapses, while C3H α7 heterozygous mice maintained robust LTP. In contrast, homozygous α7 deletion in C57 mice, which normally express lower α7nAChR levels, did not alter LTP, as had been previously reported for this strain. Thus, the threshold of Chrna7 expression required for LTP may be different in the two strains. Measurements of auditory gating, a hippocampal-dependent behavioral paradigm used to identify schizophrenia-associated sensory processing deficits, was abnormal in C3H α7 knockout mice confirming that auditory gating also requires α7nAChR expression. Our studies highlight the importance of genetic background on the regulation of synaptic plasticity and could be relevant for understanding genetic and cognitive heterogeneity in human studies of α7nAChR dysfunction in mental disorders.

Keywords: hippocampal slice, long-term potentiation, α7 nicotinic acetylcholine receptor, genetics, mouse


Nicotinic acetylcholine receptors (nAChRs) are expressed in nearly all brain regions and are assembled from combinations of α and β subunits with the predominant subtypes being either α7 homomers or α4β2 heteromers [1][2]. In the hippocampus, α7 nicotinic receptors (α7nAChRs) are found both presynaptically, on GABAergic or glutamatergic terminals, and postsynaptically on principal neurons [3][4]. Activation of nAChRs can positively modulate NMDA receptor-(NMDAR-) dependent synaptic plasticity [5][6], and it is thought that dysfunction or loss of nAChRs in aging or neurodegenerative disorders may contribute to cognitive decline.

Reduced α7nAChR function is also associated with schizophrenia. Schizophrenia is a complex neuropsychiatric disorder affecting 1% of the population [7], with a characteristic onset at 20–30 years of age presenting with numerous deleterious symptoms, including disorganized thought and behavior, cognitive impairments, sensory processing deficits, and hallucinations [8][9]. The CHRNA7 gene is linked to this disorder [10], and expression of α7nAChRs is decreased in hippocampus and other brain regions of schizophrenic patients [11][12]. Furthermore, schizophrenics have a high incidence of heavy smoking [13][14], suggesting that these individuals are self-medicating with nicotine to ameliorate their symptoms, which may be related to decreased α7nAChR function [15][16]. Indeed, it has been demonstrated in laboratory settings that nicotine administration can normalize auditory sensory gating both in schizophrenic patients [14][17] and in rodent models of schizophrenia [18]. Furthermore, smoking is also known to regulate gene expression in human hippocampus, and differentially regulates the expression of more than 75 genes in schizophrenic postmortem brain, including CHRNA7 [12]. Schizophrenia is strongly influenced by interactions between specific genetic mutations and environment during development. The issue of genetic background heterogeneity is particularly important in human studies, and the impact of reduced α7nAChRs on brain functions in schizophrenia, such as learning and memory and sensory processing, may be modified by genetic background. Here we examined a type of hippocampal synaptic plasticity thought to underlie learning and memory—long-term potentiation (LTP)—in wild-type (WT) and α7 knockout (KO) mice on two genetic backgrounds, C3H and C57/Bl6, that differ in their levels of Chrna7 gene expression; C57/Bl6 expresses approximately 15% less α7nAChR than do C3H mice [19]. Previous data for α7 KO in C57/Bl6 mice found that LTP was not impaired [20][21], which agrees with our data presented below. However, we found that deletion of the α7nAChR in C3H mice, strongly impaired LTP. Comparison of auditory gating and LTP in the C3H KO suggests that different threshold levels of α7nAChRs may be required for these phenotypes. Thus, genetic background may be a significant factor in determining the impact of reduced α7nAChR function on neuronal plasticity and behavior in both mouse models and humans with schizophrenia.

Materials and methods


Mice were originally constructed as a knockout of the Chrna7 gene on mixed background 129C57/B16 mice [22]. At the Institute for Behavioral Genetics at the University of Colorado, Boulder, CO, USA, the knockout genotype was introgressed onto C3H/Ibg (C3H) by backcrossing the α7 KO mixed background (129C57BL/6 Chrna7−/−) mice to C3H mice for 10 generations (maintaining six families). Mice from the last generation were used to establish a breeding colony at the University of Colorado Anschutz Medical Campus, Aurora, CO, USA. A recent genome diversity analysis (The Jackson Laboratory, Bar Harbor, ME, USA) indicates that the α7 KO C3H mice are at least 99.7% identical to the C3H parent strain. Similar crossings were used for α7 genotypes on the C57 background. Male animals of α7 KO, heterozygotes and WT animals on either C3H or C57 genetic backgrounds were used at 6–10 weeks of age. All animal procedures were conducted in accordance with National Institutes of Health (NIH)–United States Public Health Service guidelines and with the approval of the University of Colorado, Denver, Institutional Animal Care and Use Committee.


Mouse Hippocampal Slice Preparation

After sacrifice, the brains were rapidly removed and immersed in ice-cold, sucrose-containing cutting buffer (in mM: 87 NaCl, 2.5, KCl, 7 MgCl2, 0.5 CaCl2, 1.25 NaH2PO4, 25 D-glucose, 220 sucrose, and 25 NaHCO3) for 40–60 sec. Transverse slices (400 μm thickness) were made, stored and recorded as previously reported [23]. The artificial cerebrospinal fluid (aCSF) contained the following (in mM): 126 NaCl, 3.0 KCl, 1.0 MgSO4, 2.0 CaCl2, 1.2 NaH2PO4, 11 D-glucose, and 25.9 NaHCO3.

Electrophysiological Recordings

For each slice recording experiment, input-output (I-O) curves were generated and paired-pulse responses (PPR) were obtained, with an inter-stimulus interval of 50 ms, as previously reported [23]. Synaptic fEPSP responses were evoked with bipolar tungsten electrodes placed in the CA1 synaptic field layer. Test stimuli were delivered once every 20 sec with the stimulus intensity set to 40–50% of the maximum synaptic response. High-frequency stimulation (HFS) consisted of two trains of 100 Hz lasting 1 sec each, with an inter-train interval of 20 sec, at the control stimulus intensity. fEPSP recordings were made with a glass micropipette filled with aCSF and placed in the stratum radiatum. This stimulation produced LTP that persisted for more than 60 min in both C57 and C3H WT animals. The initial slopes of fEPSPs were calculated as the slope measured between 10–30% from the origin of the initial negative deflection. Each time point shown is an average of six 20 sec interval measurements. An average over 10 min of LTP recordings 55–65 min after HFS were used in the summary analyses in Fig. 2C. For statistical comparisons, each slice was considered a separate n.

Fig. 2
LTP is only impaired in α7 KO on the C3H genetic background. fEPSP recordings of LTP in slices from (A.) C57 and (B.) C3H WT and α7 KO, as well as WT C3H in the presence of 100 nM αBTX (BTX was applied to slices 30 min prior to ...

Auditory Gating

Mice (20–27 g) were anesthetized with chloral hydrate (400 mg/kg, ip) and pyrazole (400 mg/kg, ip) to inhibit metabolism of chloral hydrate. Mice were then placed in a mouse adapter (Neuroprobe, Cabin John, MD) for the stereotaxic instrument and the scalp incised. A stainless steel, teflon-coated recording electrode (127 μm diameter) was lowered to the CA3 region of the dorsal hippocampus, and a reference electrode was placed in the dura over the anterior cortex as previously reported [24]. Final placement was determined by the presence of complex spike activity typical of hippocampal pyramidal neurons. Miniature earphones attached to hollow ear bars, placed at the externalization of the aural canal, delivered the auditory stimuli. EEG responses to paired click stimuli were amplified and filtered at 1–500 Hz, collected and analyzed using the SciWorks acquisition and analysis program (DataWave, Loveland, CO), as previously described [18][25].


Baseline electrophysiological characteristics of hippocampal CA1 synapses are not altered by α7 gene deletion

There were no significant differences between WT and α7 KO animals on either the C57 or C3H genetic background for baseline electrophysiological parameters (input-output (I-O) curves and paired-pulse ratios (PPR; Fig. 1). In particular, although differences in basal I-O curves between WT C3H and C57 mice were noted, genetic knockout of the α7 gene had no impact on these properties. Likewise, PPR, a measure of presynaptic function consistently produced a bigger response for the second stimulation than the first in both strains, as expected, but there were no significant PPR differences between genotypes.

Fig. 1
Baseline CA1 synaptic transmission characteristics are similar for hippocampal slices from WT, α7 KO and Het mice on both the C57 and C3H genetic backgrounds. A. Representative fEPSP traces from an input-output (I-O) curve. Left panel: Traces ...

LTP is impaired by α7 gene deletion on the C3H but not C57 background

LTP induced by HFS produced similar potentiation of fEPSPs over 60 min for both WT and α7 KO mice on the C57 background (Fig. 2A). In contrast, Chrna7 gene KO on the C3H background resulted in much diminished LTP compared with its WT counterpart (Fig. 2B). However, C3H mice heterozygous for the α7 gene (Het) exhibited LTP at least as robust as WT. Thus, unlike for C57, in the C3H strain, LTP differences were significantly different between α7 KO and either WT or Het mice (for WT vs. KO, F(1,330) = 247.23 p < 0.0001; for KO vs. Het, F(1,330) = 10.66 p = 0.0012). WT C3H mice also consistently exhibited slightly greater LTP than WT C57 mice, an effect that was significant if examined over the whole time course following HFS, respectively (Fig. 2A, ,2B;2B; LTP: F(1,29) = 46.64, p < 0.0001). Average LTP data for the last 10 min are summarized in Fig. 2C.

The α7nAChR receptor selective antagonist α-bungarotoxin (αBTX) has no effect on LTP in C3H or C57 mice

Since the lack of α7nAChRs resulted in loss of LTP in C3H mice, we reasoned that this was due either to a lack of acute α7nAChR activation during induction of LTP or to some pre-existing deficit in LTP induction and/or maintenance mechanisms caused by chronic lack of α7nAChRs during development. We tested these possibilities by acutely blocking α7nAChRs with the selective, irreversible antagonist α-bungarotoxin (αBTX) administered 30 min prior to HFS. Application of αBTX produced a blunting of the initial response to HFS in C3H slices, known as post-tetanic potentiation (PTP), but did not alter the levels of LTP over 60 min for either strain (Fig. 2). We conclude that α7nAChRs do not have a prominent role in the acute expression of HFS-induced LTP in C3H or C57 mice. These receptors may, however, affect the organization of synaptic components during development, resulting in abnormal synaptic plasticity in adulthood.

Auditory Gating is impaired in C3H α7 KO mice

Auditory gating is a mechanism in the brain that filters out unnecessary information and is generally linked to focus. It is measured on the skull surface in humans as a wave of latency of 50 ms occurring after an initial auditory stimulus of 70 db. A second stimulus delivered 500 ms later is filtered or gated out in normal individuals. The ratio of the test to conditioning waves is characteristically diminished in schizophrenics [15][26]. This phenomena has been studied in rodents, where it involves hippocampal circuits and depends on α7nAChR function [27][28]. In a previous study, we found that C3H mice heterozygous for Chrna7 had impaired sensory gating compared to their WT counterparts [25]. Here, we analyzed auditory gating for α7 homozygous KO mice in comparison to WT on the C3H background (Fig. 3). While conditioning amplitudes were not significantly different, the average test amplitude of α7 KO mice was significantly greater than that for WT (***p<0.001). Thus, WT C3H mice exhibited a test-conditioning (TC) ratio of ~ 0.5, characteristic of normal gating, but α7 KO mice lacked gating with TC ratio of ~1.0, similar to the schizophrenic phenotype. TC ratios of WT mice were significantly less than those for the α7 KO mice (**p<0.01).

Fig. 3
Summary of auditory gating data for C3H mice. WT and KO C3H mice displayed similar conditioning amplitudes, but test amplitudes of KO mice were significantly greater (***p<0.001, t-test; WT (n = 10), KO (n = 7)). WT C3H mice showed ‘normal’ ...


NMDAR-dependent synaptic plasticity in the hippocampus, such as LTP and LTD, is thought to represent the molecular and cellular basis for learning and memory [29][30]. LTP was expressed in WT C3H mice, but was markedly impaired in α7 KO animals on this background. In contrast, α7 gene deletion did not alter LTP in C57/Bl6, although WT mice in this strain exhibited slightly reduced LTP compared with WT C3H. At least two explanations are possible for the LTP impairment in C3H α7 KO mice. α7nAChRs may actively contribute to NMDAR-dependent LTP via actions pre- or postsynaptically (increasing glutamate release [4] or adding to postsynaptic Ca2+ flux [6][31] [32], respectively). Thus, the α7AChR KO mice would accordingly manifest reduced LTP. Alternatively, the loss of Chrna7 expression during development may result in faulty pre- and/or postsynaptic function of signaling components necessary for LTP [33][34]. Such requirements for Chrna7 expression to form correct excitatory and inhibitory circuits during development could explain why α7nAChRs are highly abundant early in development, but drop off markedly to adult levels by about 20 days of age [35].

To test these possibilities, we examined the effect of acute blockade of α7nAChRs with the selective antagonist αBTX on LTP in WT C57 and C3H hippocampal slices. This α7 irreversible antagonist blunted the initial PTP response to HFS in C3H slices, but did not alter baseline synaptic activity or LTP from the levels observed in WT mice of either strain. The inhibition of PTP with αBTX in C3H slices is likely due to acute block of presynaptic α7nAChRs because PTP results from short-term enhancement of presynaptic function; this effect was not observed in C57 slices. However, since after 60 min LTP remained unchanged, we can conclude that α7nAChRs do not play a major acute signaling role in LTP in adult animals. Instead, the developmental hypothesis is supported, i.e., animals that develop without these receptors may have altered glutamatergic and/or GABAergic synapses, such that normal LTP cannot be induced effectively. Indeed, a recent study observed that C57 mice lacking the α7nAChR have abnormal glutamatergic synapses accompanied by functional deficits during early postnatal development [34]. It should be noted, however, that the latest time investigated in Lozada et al. [34] was 25 days of age, and it is not known whether these synaptic functional deficits persist beyond that age or are “corrected” or compensated for by the time when we measured LTP (6–10 weeks of age). Nonetheless, any such abnormal basal synaptic functions were not severe enough to alter I-O or PPR responses measured in our study for either young or older α7 KO mice on either the C3H or C57 backgrounds. Thus, the deficit in LTP for C3H KO mice could reflect impaired activation of signaling pathways, such as phosphorylation of AMPA receptors [36], that are acutely required for LTP but not for maintaining basal synaptic transmission. Future studies could address the role of developmental signaling alterations by using conditional α7nAChR knockout in adult mice [37].

Taken together, these findings suggest that the absence of α7nAChRs in the C3H mouse likely affects synaptic development to cause persistent alterations in signaling mechanisms necessary for LTP. Activation of α7nAChRs can promote removal of NMDAR-Mg2+ block and promote insertion of AMPARs into NMDAR-only “silent” synapses in development [33]. In addition, other forms of developmental regulation of NMDAR-containing synapses by neuronal nAChRs have also been identified [37][38]. In particular, activation of α7nAChRs with nicotine from postnatal day 8 – 12 resulted in increased levels of mRNA for GluN2A in auditory cortex and decreased mRNA for GluN2B in thalamus [39]. Indeed, GABAergic mechanisms may also be affected by α7 KO [40]. Thus, it is possible that loss of α7nAChRs during this critical developmental period might lead to alterations in both glutamatergic and GABAergic function that persist into adulthood resulting in impaired plasticity and aberrant behavior. Accordingly, investigation of auditory gating confirmed that KO of Chrna7 on the C3H background results in a loss of gating, consistent with impaired hippocampal processing of sensory information.

Regardless of the underlying mechanisms, the absence of α7nAChRs clearly prevented LTP in C3H animals. To the best of our knowledge the present data represents the first report of a deficit in this prototypical form of hippocampal synaptic plasticity caused by genetic knockout of the Chrna7 gene. By contrast, in α7 knockouts on the C57 background, LTP was unchanged from that observed in WT mice. Thus our data confirms other studies that knockout of the α7nAChR does not impair LTP in adult C57 mice [20][21][41], although LTP impairment was noted in aged α7 KO mice on this background [41]. As mentioned above, WT Chrna7 gene expression is approximately 15% higher in C3H than in C57 [19]. However, other differentially-expressed genes between these two strains might also account for plasticity differences in WT animals, as well as for differential impacts and compensatory and/or adaptive mechanisms in α7 KO animals.

In conclusion, we found that loss of α7nAChR expression significantly impaired NMDAR-dependent LTP at hippocampal CA1 synapses in C3H mice, while C57 mice were functionally resistant to loss of receptor expression. Interestingly, the more profound effects on synaptic plasticity in C3H mice were also accompanied by a loss of auditory gating, a hippocampal-dependent behavior that is impaired in schizophrenics and known to be more robust in WT C3H compared to C57 mice [24]. This correspondence between LTP and gating, however, did not extend to C3H heterozygotes, which had normal LTP but abnormal gating [25]. Perhaps reduced α7nAChR expression can be compensated for in the limited setting of LTP at CA1 excitatory synapses in a way not possible for gating behavior that requires overall function of hippocampal excitatory and inhibitory circuits. Expression of the human CHRNA7 gene is reduced in multiple brain regions in most schizophrenic patients. Importantly, other genetic changes in this disorder include multiple genes in the NMDAR postsynaptic density [42][43]. However, not every schizophrenic has the same gene expression changes. This heterogeneity in gene expression suggests that the underlying genetic background in human individuals may be important for the penetration and manifestation of any one given mutation. Our current study is relevant for understanding the complex interactions between α7nAChR dysfunction and genetic background.


  • Both α7nAChR function and genetic background are important in schizophrenia.
  • C57/Bl6 and C3H mice differ in background expression of α7nAChRs (C3H > C57).
  • Knockout of the α7nAChR gene impaired LTP in C3H but not C57 mice.
  • C3H knockout mice displayed abnormal auditory gating, a schizophrenic phenotype.
  • Genetic background strongly influences phenotypic expression in schizophrenia.


This work was supported by NS040701 to M.L.D.; and by DA09457, MH81177, and VAMC to S.L.


artificial cerebrospinal fluid
α7 nAChR
alpha 7 nicotinic acetylcholine receptor
alpha 7 nicotinic acetylcholine receptor gene
field excitatory postsynaptic potential
high-frequency stimulation
low-frequency stimulation
long-term depression
long-term potentiation
paired-pulse response
TC ratio
test-conditioning ratio


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Author Contributions: Conception and design were contributed by RF, SG, SL, MD. Execution of experiments and analysis of data were performed by RF, SG, KC and KS. Writing and approval of manuscript was contributed by RF, SG, SL and MD.

The authors declare that they have no conflict of interest.


1. Alkondon M, Albuquerque EX. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther. 1993;265:1455–1473. [PubMed]
2. Sudweeks S, Yakel JL. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol. 2000;527:515–528. [PubMed]
3. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci. 1998;18:1187–1195. [PubMed]
4. Cheng Q, Yakel JL. The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus. Biochem Pharmacol. 2015;97:439–444. [PMC free article] [PubMed]
5. Halff AW, Gomez-Varela D, John D, Berg DK. A novel mechanism for nicotinic potentiation of glutamatergic synapses. J Neurosci. 2014;34:2051–2064. [PMC free article] [PubMed]
6. Kroker KS, Rast G, Rosenbrock H. Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP. Eur J Pharmacol. 2011;671:26–32. [PubMed]
7. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia (Review) Cochrane Database of Systematic Reviews. 2013;2 doi: 10.1002/14651858.CD007253.pub3. Art. No.: CD007253. [PubMed] [Cross Ref]
8. Freedman R. Schizophrenia. N Engl J Med. 2003;349:1738–1749. [PubMed]
9. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, Freedman R, Adams CE. Cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psych. 2010;51:535–549. [PMC free article] [PubMed]
10. Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufman CA, Tsuang MT, Farone SV, Malaspina D, Svrakic DM, Sanders A, Gejman P. Linkage disequilibrium for schizophrenia at the chromosome 15q13–14 locus of the α7-nicotinic acetylcholine receptor subunit gene (CHRNA7) Am J Med Genet. 2001;105:20–22. [PubMed]
11. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiat. 1995;38:22–33. [PubMed]
12. Mexal S, Berger R, Logel J, Ross RG, Freedman R, Leonard S. Differential Regulation of alpha 7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J Mol Neurosci. 2010;40:185–195. [PMC free article] [PubMed]
13. DeLeon J, Tracy J, McCann E, McGrory A, Diaz FJ. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res. 2002;56:55–65. [PubMed]
14. Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, Gault J, Lee MJ, Logel J, Olincy A, Ross RG, Stevens K, Sullivan B, Vianzon R, Virnich DE, Waldo M, Walton K, Freedman R. Smoking and mental illness. Pharmacol Biochem Behav. 2001;70:561–570. [PubMed]
15. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizo Bull. 1998;24:189–202. [PubMed]
16. Leonard S, Mexal S, Berger R, Olincy A, Freedman R. Smoking and schizophrenia: evidence for self-medication. Schizophr Bull. 2007;33:262–263.
17. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150:1856–1861. [PubMed]
18. Stevens KE, Wear KD. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animals models. Pharmacol Biochem Behav. 1997;57:869–874. [PubMed]
19. Marks MJ, Romm E, Campbell SM, Collins AC. Variation of nicotinic binding sites among inbred strains. Pharm Biochem Behav. 1989;33:679–689. [PubMed]
20. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF. Deletion of the α7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer’s disease. J Neurosci. 2009;29:8805–8815. [PMC free article] [PubMed]
21. Nakauchi S, Sumikawa K. Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice. Eur J Neurosci. 2012;35:1381–1395. [PMC free article] [PubMed]
22. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, Biasi MDe, Dani JA, Patrick JW, Beaudet AL. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci. 1997;17:9165–9171. [PubMed]
23. Buard I, Coultrap SJ, Freund RK, Lee YS, Dell’Acqua ML, Silva AJ, Bayer KU. CaMKII “autonomy” is required for initiating but not for maintaining neuronal long-term information storage. J Neurosci. 2010;30:8214–8220. [PMC free article] [PubMed]
24. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. Genetic correlation of hippocampal auditory evoked response and α-bungarotoxin binding in inbred mouse strains. Neuropsychopharmacol. 1996;15:152–162. [PubMed]
25. Adams CE, Yoncheck JC, Zheng L, Collins AC, Stevens KE. Altered hippocampal circuit function in C3H α7 null mutant heterozygous mice. Brain Res. 2008;1194:138–145. [PMC free article] [PubMed]
26. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, Drebing C, Berger R, Venn D, Sirota P, Zerbe G, Olincy A, Ross RG, Adler LE, Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiat. 2002;59:1085–1096. [PubMed]
27. Luntz-Leybman V, Bickford P, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 1992;587:130–136. [PubMed]
28. Stevens KE, Kem WR, Mahnir VM, Freedman R. Selective alpha7-nicotinic agonists normalize inhibition in auditory response in DBA mice. Psychopharmacol. 1998;136:320–327. [PubMed]
29. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39. [PubMed]
30. Malenka RC, Bear MF. LTP and LTD: An embarrassment of riches. Neuron. 2004;44:5–21. [PubMed]
31. Ji D, Lape R, Dani JA. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron. 2001;31:131–141. [PubMed]
32. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium. J Neurosci. 1993;13:596–604. [PubMed]
33. Maggi L, Magueresse CL, Changeux JP, Cherubini E. Nicotine activates immature “silent” connections in the developing hippocampus. Proc Nat Acad Sci. 2003;100:2059–2064. [PubMed]
34. Lozada AF, Wang X, Gounko NV, Massey KA, Duan J, Liu Z, Berg DK. Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors. J Neurosci. 2012;32:7651–7661. [PMC free article] [PubMed]
35. Hernandez CM, Cortez I, Gu Z, Col’on-Saez JO, Lamb PW, Wakamiya M, Yakel JL, Dineley KT. Research tool: validation of floxed α7 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches. J Physiol. 2014;592:3201–3214. [PubMed]
36. Lee HK, Takamiya K, Han J-S, Man H, Kim C-H, Rumbaugh G, Yu S, Ding L, He C, Petralia RS, Wenthold RJ, Gallagher M, Huganir RL. Phosphorylation of the AMPA receptor subunit is required for synaptic plasticity and retention of spatial memory. Cell. 2003;112:631–643. [PubMed]
37. Zhang X, Liu C, Miao H, Gong Z-H, Nordberg A. Postnatal changes of nicotinic acetylcholine receptor α2, α3, α4, α7, and β2 subunits genes expression in rat brain. Int J Dev Neurosci. 1998;16:507–518. [PubMed]
38. Metherate R, Hsieh CY. Regulation of glutamate synapses by nicotinic acetylcholine receptors in auditory cortex. Neurobiol Learn Mem. 2003;80:285–290. [PubMed]
39. Hsieh CY, Leslie FM, Metherate R. Nicotine exposure during a postnatal critical period alters NR2A and NR2B mRNA expression in rat auditory forebrain. Dev Brain Res. 2002;133:19–25. [PubMed]
40. Liu ZP, Neff RA, Berg DK. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science. 2006;314:1610–1613. [PubMed]
41. Ma L, Turner D, Zhang J, Wang Q, Wang M, Shen J, Zhang S, Wu J. Deficits of synaptic functions in hippocampal slices prepared from aged mice null α7 nicotinic acetylcholine receptors. Neurosci Lett. 2014;570:97–101. [PubMed]
42. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, Leonard S. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Mol Brain Res. 2005;139:317–332. [PubMed]
43. Moghaddam B, Javitt D. From Revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacol. 2012;37:4–15. [PMC free article] [PubMed]